N-(2-Hydroxyethyl)-N-methylacetamide - CAS 15567-95-0
Catalog: |
BB011139 |
Product Name: |
N-(2-Hydroxyethyl)-N-methylacetamide |
CAS: |
15567-95-0 |
Synonyms: |
N-(2-hydroxyethyl)-N-methylacetamide |
IUPAC Name: | N-(2-hydroxyethyl)-N-methylacetamide |
Description: | N-(2-Hydroxyethyl)-N-methylacetamide (CAS# 15567-95-0) is a useful research chemical. |
Molecular Weight: | 117.15 |
Molecular Formula: | C5H11NO2 |
Canonical SMILES: | CC(=O)N(C)CCO |
InChI: | InChI=1S/C5H11NO2/c1-5(8)6(2)3-4-7/h7H,3-4H2,1-2H3 |
InChI Key: | OBSKGKGKPGOOTB-UHFFFAOYSA-N |
Appearance: | Liquid |
MDL: | MFCD10048086 |
LogP: | -0.54300 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021078285-A1 | Cycloalkyl-based and heterocycloalkyl-based inhibitors, preparation method therefor and use thereof | 20191023 |
WO-2021078312-A1 | Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof | 20191023 |
US-2020368361-A1 | Rifamycin analogs and antibody-drug conjugates thereof | 20181221 |
CN-113226470-A | Rifamycin analogs and antibody-drug conjugates thereof | 20181221 |
KR-20210107752-A | Rifamycin analogs and antibody-drug conjugates thereof | 20181221 |
PMID | Publication Date | Title | Journal |
22220077 | 20111101 | 7-(3-Nitro-phen-yl)-9,10-dihydro-7H-benzo[h]cyclo-penta-[b]quinolin-8(11H)-one | Acta crystallographica. Section E, Structure reports online |
21754641 | 20110601 | Poly[dinitrato[μ(3)-2,4,6-tris-(4-pyrid-yl)-1,3,5-triazine]cobalt(II)] | Acta crystallographica. Section E, Structure reports online |
21588727 | 20100825 | 1-(Prop-2-en-1-yl)-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium bromide monohydrate | Acta crystallographica. Section E, Structure reports online |
21587984 | 20100626 | 1-Benzyl-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium chloride monohydrate | Acta crystallographica. Section E, Structure reports online |
20462406 | 20100512 | Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin | Microbial cell factories |
Complexity: | 82.5 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 117.078978594 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 117.078978594 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 40.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[1115-70-4]
1,1-Dimethylbiguanide hydrochloride
-
[1032314-85-4]
Benzamide, N-[4-methyl-3-[[4-(6-methyl-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-
-
[6279-86-3]
Triethyl methanetricarboxylate
-
[6342-17-2]
1,4-Bis(acryloyl)piperazine
-
[86938-64-9]
4,5-Dibromophthalonitrile
INDUSTRY LEADERS TRUST OUR PRODUCTS